fashion -WSS

fashion

author：explore 2025-09-27 23:11:50 - browse：9

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

focus

hotspot

WSS

7 more heat

At Orexo, a ‘turning point’ for everything but digital health

Key House panel plots a new health care package

I learned firsthand about improving diversity in clinical trials

Tocagen's brain cancer gene therapy trial continues. Investors worry

Why hospitals are withdrawing from US News rankings

Wikipedia

fashion

hotspot

Affirmative action in medical school literally saved lives

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Affirmative action in medical school literally saved lives

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare to cover more brain scans for Alzheimer’s patients

Medical records are filled with copy

A public scorecard can help hold safety

Drug repurposing or repositioning? The language matters

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

knowledge

Indian pharmaceutical industry in denial over drug

In early work, researchers turn to CRISPR to treat Alzheimer's

EF3 tornado rips through North Carolina amid extreme weather nationwide

Key House panel plots a new health care package

I learned firsthand about improving diversity in clinical trials

Key House panel plots a new health care package

entertainment

focus

hotspot

Wikipedia